A phase I pharmacokinetic trial of sonic hedgehog (SHH) antagonist GDC-0449 in pediatric patients with recurrent or refractory medulloblastoma: A Pediatric Brain Tumor Consortium study (PBTC 25).

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-06-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2010.28.18_SUPPL.CRA9501PMID 27937459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Chemotherapeutic Strategies in Brain Tumors

  2018cites this paper
• Hedgehog regulates cerebellar progenitor cell and medulloblastoma apoptosis.

  2015cites this paper
• Treatment approach for recurrent medulloblastoma

  2015cites this paper
• The WIP1 Oncogene Promotes Progression and Invasion of Aggressive Medulloblastoma Variants

  2014cites this paper
• The rationale for targeted therapies in medulloblastoma.

  2014cites this paper
• Future of clinical genomics in pediatric oncology.

  2013cites this paper
• New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies.

  2013cites this paper
• Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience

  2013cites this paper
• Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

  2013cites this paper
• The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma

  2013cites this paper
• Receptor tyrosine kinase gene copy numbers and protein expression in astrocytic brain tumors : With special reference to KIT, PDGFRA, VEGFR2 and EGFR

  2012cites this paper
• The potential origin of glioblastoma initiating cells.

  2012cites this paper
• Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.

  2012cites this paper
• Receptor tyrosine kinase gene copy numbers and protein expression in astrocytic brain tumors-With special reference to KIT , PDGFRA , VEGFR 2 and EGFR

  2012cites this paper
• Therapeutic potential of hedgehog signaling inhibitors in cancer: rationale and clinical data

  2012cites this paper
• The Hedgehog's tale: developing strategies for targeting cancer

  2011cites this paper
• Hedgehog Signaling in Pediatric Brain Tumors

  2011cites this paper
• Targeting Children’s Brain Tumors: Development of Hedgehog Pathway Inhibitors for Medulloblastoma

  2011cites this paper
• Two faces of evil : cancer and neurodegeneration

  2011cites this paper